Arvinas Inc. (ARVN)
8.26
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 144 ARVINAS, INC. Filed by: Berkowitz Noah
July 9, 2026 4:12 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Smaldone Alsup Laurie
June 26, 2026 4:24 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Norwalk Leslie V
June 26, 2026 4:23 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Morrison Briggs
June 26, 2026 4:23 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Kennedy Edward Moore Jr.
June 26, 2026 4:22 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Cunningham Everett
June 26, 2026 4:22 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Bain Linda
June 26, 2026 4:21 PM - SEC Filing
Form 8-K ARVINAS, INC. For: Jun 24
June 25, 2026 4:18 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 24 Filed by: Saik Andrew
June 24, 2026 5:20 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Saik Andrew
June 23, 2026 6:10 PM - SEC Filing
Arvinas CMO to depart in July as company begins search
June 22, 2026 4:13 PM - StreetInsider
Form 8-K ARVINAS, INC. For: Jun 22
June 22, 2026 4:10 PM - SEC Filing
Form 4 ARVINAS, INC. For: Jun 17 Filed by: Cacace Angela M
June 18, 2026 4:07 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Cacace Angela M
June 17, 2026 9:00 AM - SEC Filing
Arvinas and Pfizer complete Rigel license deal for vepdegestrant
June 16, 2026 4:33 PM - StreetInsider
Form 8-K ARVINAS, INC. For: Jun 11
June 16, 2026 4:30 PM - SEC Filing
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
June 4, 2026 8:00 AM - StreetInsider
Form 8-K ARVINAS, INC. For: Jun 02
June 2, 2026 4:40 PM - SEC Filing
Arvinas to Present at Jefferies Global Healthcare Conference
May 29, 2026 4:01 PM - StreetInsider
Form 4 ARVINAS, INC. For: May 21 Filed by: Teel Randy
May 22, 2026 4:16 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Teel Randy
May 20, 2026 5:34 PM - SEC Filing
Arvinas Employees Give Back During Company-wide Impact Day
May 18, 2026 10:30 AM - Globe NewsWire
Form 4 ARVINAS, INC. For: May 11 Filed by: Saik Andrew
May 13, 2026 4:20 PM - SEC Filing
Form 4 ARVINAS, INC. For: May 11 Filed by: Loomis David K
May 13, 2026 4:18 PM - SEC Filing
Form 4 ARVINAS, INC. For: May 11 Filed by: Cacace Angela M
May 13, 2026 4:17 PM - SEC Filing
Form 4 ARVINAS, INC. For: May 11 Filed by: Berkowitz Noah
May 13, 2026 4:16 PM - SEC Filing
Form 4 ARVINAS, INC. For: May 11 Filed by: Teel Randy
May 13, 2026 4:16 PM - SEC Filing
Arvinas Inc. (ARVN) PT Raised to $16 at BofA Securities
May 13, 2026 2:53 PM - StreetInsider
Arvinas Inc. (ARVN) PT Raised to $18 at BTIG
May 13, 2026 6:04 AM - StreetInsider
Arvinas Inc. (ARVN) PT Raised to $20 at Barclays
May 13, 2026 4:22 AM - StreetInsider
Form 8-K ARVINAS, INC. For: May 12
May 12, 2026 7:16 AM - SEC Filing
Form 8-K ARVINAS, INC. For: May 11
May 12, 2026 7:15 AM - SEC Filing
Arvinas, Inc. (ARVN) Tops Q1 EPS by 3c
May 12, 2026 7:07 AM - StreetInsider
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026 7:05 AM - Globe NewsWire
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:00 AM - Globe NewsWire
Form 10-Q ARVINAS, INC. For: Mar 31
May 11, 2026 5:19 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Saik Andrew
May 8, 2026 6:06 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Cacace Angela M
May 8, 2026 6:06 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Berkowitz Noah
May 8, 2026 6:06 PM - SEC Filing
Form 144 ARVINAS, INC. Filed by: Teel Randy
May 8, 2026 6:05 PM - SEC Filing
Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
May 5, 2026 7:00 AM - Globe NewsWire
Arvinas Inc. (ARVN) PT Raised to $24 at Citi
May 4, 2026 5:13 AM - StreetInsider
BTIG Reiterates Buy Rating on Arvinas Inc. (ARVN)
May 1, 2026 3:39 PM - StreetInsider
Arvinas shares gain as FDA approves breast cancer drug Veppanu
May 1, 2026 1:12 PM - StreetInsider
Form 8-K ARVINAS, INC. For: May 01
May 1, 2026 12:58 PM - SEC Filing
FDA approves first PROTAC therapy VEPPANU for breast cancer
May 1, 2026 12:43 PM - StreetInsider
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
May 1, 2026 12:43 PM - Globe NewsWire
Form ARS ARVINAS, INC. For: Dec 31
April 29, 2026 9:47 AM - SEC Filing
Form DEFA14A ARVINAS, INC.
April 29, 2026 9:32 AM - SEC Filing
Form DEF 14A ARVINAS, INC. For: Jun 24
April 29, 2026 9:32 AM - SEC Filing
Form SCHEDULE 13G ARVINAS, INC. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 28, 2026 4:16 PM - SEC Filing
Full Article List
